Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models Christopher.Koski@bruker.com Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models Read More »
ADP-dependent platelet activation is required for thrombus formation in mice exposed to simulated flight conditions Christopher.Koski@bruker.com ADP-dependent platelet activation is required for thrombus formation in mice exposed to simulated flight conditions Read More »
IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models Christopher.Koski@bruker.com IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models Read More »
Glycolysis maintains effector function of lung Th17 TRM cells in precision cut lung slices Christopher.Koski@bruker.com Glycolysis maintains effector function of lung Th17 TRM cells in precision cut lung slices Read More »
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models Christopher.Koski@bruker.com Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models Read More »
A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD-(L)1 in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Christopher.Koski@bruker.com A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD-(L)1 in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Read More »
Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function | Cancer Immunology Research | American Association for Cancer Research Christopher.Koski@bruker.com Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function | Cancer Immunology Research | American Association for Cancer Research Read More »
TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial Christopher.Koski@bruker.com TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial Read More »
A prospective observational study of inflammatory mediators in cerebrospinal fluid after intraoperative radiotherapy of brain tumors Christopher.Koski@bruker.com A prospective observational study of inflammatory mediators in cerebrospinal fluid after intraoperative radiotherapy of brain tumors Read More »
Cilta-cel CAR T cells as an effective and well tolerated treatment for POEMS: a case study Christopher.Koski@bruker.com Cilta-cel CAR T cells as an effective and well tolerated treatment for POEMS: a case study Read More »
